Read More

EXCLUSIVE: Longeveron Reports Co. Entered Into Sponsored Clinical Research Deal With Japan’s National Center For Geriatrics And Gerontology, Juntendo University Hospital To Explore Safety, Efficacy Of Lomecel-B In Older Subjects

Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or the "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and certain life-threatening conditions,


Read More

The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week

Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting season and ahead of the holiday week.